Welcure Drugs Announces Resignation of Company Secretary & Compliance Officer
Welcure Drugs & Pharmaceuticals Ltd 路 Change in Management 路 19 Jun 2026, 9:37 pm
Welcure Drugs Announces Resignation of Company Secretary & Compliance Officer Welcure Drugs and Pharmaceuticals announced the resignation of Ms. Palak Jain from her roles as Company Secretary, Compliance Officer, and Key Managerial Personnel. The resignation is effective from the close of business on 19th Jun'26. The company stated the reason for her departure was personal reasons and other professional commitments. The Board of Directors has noted and accepted her resignation.
Original exchange filing (PDF)
More announcements from Welcure Drugs & Pharmaceuticals Ltd
- Approval of the Audited Standalone Financial Results and Audited Standalone Financial Statements 路 02 Nov 2026
- Outcome of the Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Ltd held on today i.e. Tuesday, 14th July, 2026. 路 14 Jul 2026
- Outcome of the Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Limited held on Today i.e. Friday, 19th June, 2026 路 19 Jun 2026
- Audited Standalone Financial Results for the Quarter and Year Ended 31st March, 2026 路 30 May 2026
- Outcome of the Meeting of Board of Directors of the Company held on today i.e. Friday, 29th May, 2026 路 30 May 2026
- Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Audited Financial .... 路 29 May 2026
- <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> .... 路 23 Apr 2026
- Unaudited Financials Results for the 3rd Quarter ended on 31st December, 2025 路 13 Feb 2026
